Show simple item record

dc.contributor.authorXu, X.en_US
dc.contributor.authorHan, L.en_US
dc.contributor.authorDuan, L.en_US
dc.contributor.authorZhao, Y.en_US
dc.contributor.authorYang, H.en_US
dc.contributor.authorZhou, B.en_US
dc.contributor.authorMa, R.en_US
dc.contributor.authorYuan, R.en_US
dc.contributor.authorZhou, H.en_US
dc.contributor.authorLiu, Z.en_US
dc.date.accessioned2016-05-19T18:16:18Z
dc.date.available2016-05-19T18:16:18Z
dc.date.issued2013en_US
dc.identifier.citationXu, X.; Han, L.; Duan, L.; Zhao, Y.; Yang, H.; Zhou, B., et al. (2013). Association between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients. Br J Clin Pharmacol, February 2013, 75(2):522-534. doi: http://dx.doi.org/10.1111/j.1365-2125.2012.04379.xen_US
dc.identifier.issn03065251en_US
dc.identifier.urihttp://hdl.handle.net/10504/87706
dc.titleAssociation between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patientsen_US
dc.typeJournal Articleen_US
dc.description.volume75en_US
dc.title.workBritish Journal of Clinical Pharmacologyen_US
dc.description.pages522-534en_US
dc.date.year2013en_US
dc.date.monthFebruaryen_US
dc.description.issue2en_US
dc.program.unitSchool of Medicineen_US
dc.program.unitDepartment of Medicineen_US
dc.program.unitEndocrinologyen_US
dc.program.unitOsteoporosisen_US
dc.url.link1http://doi.org/10.1111/j.1365-2125.2012.04379.xen_US
dc.contributor.cuauthorZhao, Yingchunen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record